<PublisherName>Gostaresh Afzar Hamara</PublisherName>
<JournalTitle>Iranian Journal of Medical Informatics</JournalTitle>
<ArticleTitle>Review of the Effectiveness of Information and Communication Technology (ICTs) in the Treatment of Type 1 and Type 2 Diabetes</ArticleTitle>
<Affiliation>. Nazarie951@mums.ac.ir</Affiliation>
<Abstract>Introduction: In the field of health, information and communication technology plays an important role, the world is experiencing the era of communication, the field of health is not asymmetrical. According to the study, Iran is one of the countries that is at high risk of diabetes, and continues to increase in Iran and in most countries. The purpose of this paper is to review the literature on the effectiveness of Information and Communication Technology (ICTs) in the treatment of type 1 and type 2 diabetes.Material and Methods: This study was conducted as a review and through a search of valid information databases such as PubMed, Science direct, and Google Scholar. After the final extraction from the 106 papers in the cellular field 37% and 36% in telemedicine and 27% in the Internet topic from 2010 to 2018, were finalized.Results: The findings of the study showed that the recent developments in information technology combined with services for cost optimization have increased and the current use of information technology (IT) offers unique opportunities for patients with diabetes. Internet, mobile phone and telemedicine services can facilitate and improve communication between patients and healthcare professionals and play an important role in managing diabetes. The growing challenge is the proper management of diabetes to play an important role by employing innovative approaches aimed at improving patient outcomes and reducing the incidence of adverse healthcare systems.Conclusion: This study is an overview of information and communication technology research in diabetes management and can help researchers measure the effectiveness of information and communication technology in diabetes self-care and therapeutic systems in different areas and motivate self-management. Cost reduction, technology acceptance and satisfaction.</Abstract>


  • There are currently no refbacks.